Blog

Editorial: Mesenchymal stem cells may be a credible alternative therapy to fight with COVID-19 pandemic Drs. Anand Srivastava, Prabhat Soni - GIOSTAR

Editorial: Mesenchymal stem cells may be a credible alternative therapy to fight with COVID-19 pandemic

Drs. Anand Srivastava and Prabhat Soni write in a medical journal on the potential benefits of stem cells in fighting against COVID-19. GIOSTAR recently received FDA Approval Under Compassionate Use to treat COVID-19 patients under compassionate use.

GIOSTAR Speaks with Dr. Amy Killen on Their Efforts to Treat COVID-19 with Stem Cells GIOSTAR Talks to Dr. Amy Killen About COVID-19 and Stem Cells

GIOSTAR Speaks with Dr. Amy Killen on Their Efforts to Treat COVID-19 with Stem Cells

GIOSTAR Co-Founders Dr. Anand Srivastava and Deven Patel recently spoke with Dr. Amy Killen about the company's ongoing research efforts related to coronavirus (COVID-19). Dr. Anand explains in great detail the mechanisms underlying the disease, including cytokine storms and the potential immunomodulatory benefits of mesenchymal [...]
Vitro Biopharma Signs MOU with GIOSTAR for COVID-19 IND Using AlloRx Stem Cells GIOSTAR | Vitro Biopharma

Vitro Biopharma Signs MOU with GIOSTAR for COVID-19 IND Using AlloRx Stem Cells

GOLDEN, CO / ACCESSWIRE / June 2, 2020 / Vitro Diagnostics, Inc. (OTC PINK:VODG), dba Vitro entered into an exclusive Memorandum of Understanding (MOU) with Global Institute of Stem Cell Therapy and Research, Inc. ("GIOSTAR") a leading stem cell research institute based in San Diego, California. Under this agreement, [...]